Guangrong Zheng

Citované v

	Všetky	Od 2020
Citácie	5104	3649
h-index	37	28
i10-index	88	47

1100

550

275

825

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202516 19 11 11 28 35 33 68 55 72 124 83 120 124 116 104 87 143 161 303 525 777 816 1035 180

Verejný prístup

všetky položky

99 článkov

3 články

dostupné

nedostupné

Na základe mandátov na financovanie

Spoluautori

Peter A. CrooksProfessor and Chair of Pharmaceutical Sciences, University of Arkansas for Medical SciencesOverená e-mailová adresa na: uams.edu
Daohong ZhouUniversity of Texas Health Science Center at San AntonioOverená e-mailová adresa na: uthscsa.edu
Linda DwoskinProfessor, University of KentuckyOverená e-mailová adresa na: uky.edu
XUAN ZHANGProfessor, Shanghai Institute of Materia Medica, CASOverená e-mailová adresa na: simm.ac.cn
Peiyi ZhangChemist, University of FloridaOverená e-mailová adresa na: cop.ufl.edu
Xingui LiuUniversity of FloridaOverená e-mailová adresa na: ufl.edu
Sajid KhanAssistant Professor at the University of Texas Health Science Center San AntonioOverená e-mailová adresa na: uthscsa.edu
Dongwen Lv (Lyu)Department of Biochem & Structural Biology, GCCRI, UT Health San AntonioOverená e-mailová adresa na: uthscsa.edu
Yonghan HeProfessor, Kunming Institute of Zoology, Chinese Academy of SciencesOverená e-mailová adresa na: mail.kiz.ac.cn
Dinesh ThummuriUniversity of FloridaOverená e-mailová adresa na: cop.ufl.edu
Yaxia YuanUniversity of Texas Health Science Center at San AntonioOverená e-mailová adresa na: uthscsa.edu
weizhou zhangSpensor Professor of Pathology, Immunology and Laboratory Medicine, University of FloridaOverená e-mailová adresa na: ufl.edu
Vivekananda Budamagunta, PhD.Scientist, Nautilus BiotechnologyOverená e-mailová adresa na: nautilus.bio
Yufeng XiaoUniversity of FloridaOverená e-mailová adresa na: cop.ufl.edu
Jing PeiPh.D., Pharmaceutical Sciences, University of FloridaOverená e-mailová adresa na: ufl.edu
Wei LuEast China Normal UniversityOverená e-mailová adresa na: chem.ecnu.edu.cn
Nan HuaUniversity of FloridaOverená e-mailová adresa na: ufl.edu
Daiqing LiaoAssociate Professor, University of FloridaOverená e-mailová adresa na: ufl.edu
Seth Davin NorrholmAssociate ProfessorOverená e-mailová adresa na: wayne.edu
Satheesh GujarathiUniversity of Arkansas for Medical SciencesOverená e-mailová adresa na: uams.edu

Sledovať

Guangrong Zheng

Professor, University of Florida

Overená e-mailová adresa na: cop.ufl.edu

Medicinal Chemistry Organic Chemistry Chemical Biology Drug Discovery


Názov Zoradiť podľa citácií Zoradiť podľa roka Zoradiť podľa názvu	Citované v Citované v	Rok
A selective BCL-X_L PROTAC degrader achieves safe and potent antitumor activity S Khan, X Zhang, D Lv, Q Zhang, Y He, P Zhang, X Liu, D Thummuri, ... Nature medicine 25 (12), 1938-1947, 2019	528	2019
Discovery of piperlongumine as a potential novel lead for the development of senolytic agents Y Wang, J Chang, X Liu, X Zhang, S Zhang, X Zhang, D Zhou, G Zheng Aging (Albany NY) 8 (11), 2915, 2016	273	2016
Therapy-induced senescence: opportunities to improve anticancer therapy PG Prasanna, DE Citrin, J Hildesheim, MM Ahmed, S Venkatachalam, ... JNCI: Journal of the National Cancer Institute 113 (10), 1285-1298, 2021	256	2021
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity Y He, X Zhang, J Chang, HN Kim, P Zhang, Y Wang, S Khan, X Liu, ... Nature communications 11 (1), 1996, 2020	224	2020
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics S Khan, Y He, X Zhang, Y Yuan, S Pu, Q Kong, G Zheng, D Zhou Oncogene 39 (26), 4909-4924, 2020	206	2020
Vesicular monoamine transporter 2: role as a novel target for drug development G Zheng, LP Dwoskin, PA Crooks The AAPS journal 8, E682-E692, 2006	171	2006
The curcumin analog EF24 is a novel senolytic agent W Li, Y He, R Zhang, G Zheng, D Zhou Aging (Albany NY) 11 (2), 771, 2019	143	2019
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity D Lv, P Pal, X Liu, Y Jia, D Thummuri, P Zhang, W Hu, J Pei, Q Zhang, ... Nature communications 12 (1), 6896, 2021	122	2021
Oxidation resistance 1 is a novel senolytic target X Zhang, S Zhang, X Liu, Y Wang, J Chang, X Zhang, SG Mackintosh, ... Aging cell 17 (4), e12780, 2018	119	2018
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas Y He, R Koch, V Budamagunta, P Zhang, X Zhang, S Khan, D Thummuri, ... Journal of hematology & oncology 13, 1-13, 2020	101	2020
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies Y He, S Khan, Z Huo, D Lv, X Zhang, X Liu, Y Yuan, R Hromas, M Xu, ... Journal of Hematology & Oncology 13, 1-24, 2020	96	2020
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs Y Xiao, J Wang, LY Zhao, X Chen, G Zheng, X Zhang, D Liao Chemical Communications 56 (68), 9866-9869, 2020	94	2020
Cellular senescence and radiation-induced pulmonary fibrosis Y He, D Thummuri, G Zheng, P Okunieff, DE Citrin, Z Vujaskovic, D Zhou Translational Research 209, 14-21, 2019	92	2019
Extending the analysis of nicotinic receptor antagonists with the study of α6 nicotinic receptor subunit chimeras RL Papke, LP Dwoskin, PA Crooks, G Zheng, Z Zhang, JM McIntosh, ... Neuropharmacology 54 (8), 1189-1200, 2008	92	2008
Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity Y He, W Li, D Lv, X Zhang, X Zhang, YT Ortiz, V Budamagunta, J Campisi, ... Aging cell 19 (3), e13117, 2020	91	2020
Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity X Zhang, D Thummuri, X Liu, W Hu, P Zhang, S Khan, Y Yuan, D Zhou, ... European journal of medicinal chemistry 192, 112186, 2020	85	2020
Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters DK Miller, PA Crooks, G Zheng, VP Grinevich, SD Norrholm, LP Dwoskin The Journal of pharmacology and experimental therapeutics 310 (3), 1035-1045, 2004	81	2004
Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-X L X Zhang, D Thummuri, Y He, X Liu, P Zhang, D Zhou, G Zheng Chemical Communications 55 (98), 14765-14768, 2019	76	2019
Overcoming cancer drug resistance utilizing PROTAC technology MR Burke, AR Smith, G Zheng Frontiers in Cell and Developmental Biology 10, 872729, 2022	74	2022
Stereoselective Total Synthesis of (3R,8S)-Falcarindiol, a Common Polyacetylenic Compound from Umbellifers G Zheng, W Lu, J Cai Journal of natural products 62 (4), 626-628, 1999	74	1999

Systém momentálne nemôže vykonať operáciu. Skúste to neskôr.

Články 1–20

Citácie za rok

Duplicitné citácie

Zlúčené citácie

Pridať spoluautorovSpoluautori

Sledovať

Citované v

Spoluautori